Robert W. Baird Cuts Owens & Minor (NYSE:OMI) Price Target to $14.00

Owens & Minor (NYSE:OMI) had its target price reduced by Robert W. Baird from $15.00 to $14.00 in a research note released on Tuesday morning,Benzinga reports. They currently have a neutral rating on the stock.

Other research analysts also recently issued research reports about the company. UBS Group reduced their target price on Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a report on Tuesday, November 5th. Barclays lowered their price objective on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 5th. Finally, Citigroup lowered their price target on Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a report on Tuesday, November 5th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Owens & Minor currently has an average rating of “Hold” and a consensus target price of $18.50.

Owens & Minor Trading Down 2.9 %

Shares of OMI stock opened at $8.64 on Tuesday. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. The business has a 50-day moving average price of $13.51 and a two-hundred day moving average price of $14.17. Owens & Minor has a 12-month low of $8.57 and a 12-month high of $28.35. The firm has a market cap of $666.08 million, a P/E ratio of -13.29, a price-to-earnings-growth ratio of 0.40 and a beta of 0.48.

Owens & Minor (NYSE:OMI) last released its earnings results on Monday, November 4th. The company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.41 by $0.01. The company had revenue of $2.72 billion during the quarter, compared to analyst estimates of $2.68 billion. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. Owens & Minor’s revenue for the quarter was up 5.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.44 EPS. Equities analysts anticipate that Owens & Minor will post 1.49 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CFO Jonathan A. Leon sold 5,282 shares of Owens & Minor stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $11.82, for a total value of $62,433.24. Following the completion of the transaction, the chief financial officer now owns 130,822 shares in the company, valued at approximately $1,546,316.04. This trade represents a 3.88 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 2.62% of the stock is currently owned by company insiders.

Institutional Trading of Owens & Minor

Several institutional investors have recently added to or reduced their stakes in the company. LHM Inc. lifted its stake in Owens & Minor by 4.1% in the fourth quarter. LHM Inc. now owns 175,792 shares of the company’s stock worth $2,298,000 after purchasing an additional 6,860 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Owens & Minor by 13.6% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,305,043 shares of the company’s stock worth $30,127,000 after purchasing an additional 276,807 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in Owens & Minor by 6.0% in the fourth quarter. Bank of New York Mellon Corp now owns 622,921 shares of the company’s stock worth $8,142,000 after purchasing an additional 35,105 shares during the last quarter. Principal Financial Group Inc. lifted its stake in Owens & Minor by 2.9% in the fourth quarter. Principal Financial Group Inc. now owns 358,907 shares of the company’s stock worth $4,691,000 after purchasing an additional 10,152 shares during the last quarter. Finally, Blue Trust Inc. lifted its stake in Owens & Minor by 57.4% in the fourth quarter. Blue Trust Inc. now owns 4,387 shares of the company’s stock worth $57,000 after purchasing an additional 1,600 shares during the last quarter. Institutional investors own 98.04% of the company’s stock.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.